04.04.2015 Views

Aarkstore - Blepharitis - Pipeline Review, H1 2015

Global Markets Directs, “Blepharitis - Pipeline Review, H1 2015”, provides an overview of the Blepharitiss therapeutic pipeline. For more details : http://goo.gl/cIIc6W

Global Markets Directs, “Blepharitis - Pipeline Review, H1 2015”, provides an overview of the Blepharitiss therapeutic pipeline.

For more details : http://goo.gl/cIIc6W

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Aarkstore</strong> - <strong>Blepharitis</strong> -<br />

<strong>Pipeline</strong> <strong>Review</strong>, <strong>H1</strong> <strong>2015</strong><br />

www.aarkstore.com


Summary<br />

Global Markets Directs, “<strong>Blepharitis</strong> - <strong>Pipeline</strong> <strong>Review</strong>, <strong>H1</strong> <strong>2015</strong>”, provides an overview<br />

of the <strong>Blepharitis</strong>s therapeutic pipeline.<br />

This Market Research Report provides comprehensive information on the therapeutic<br />

development for <strong>Blepharitis</strong>, complete with comparative analysis at various stages,<br />

therapeutics assessment by drug target, mechanism of action (MoA), route of administration<br />

(RoA) and molecule type, along with latest updates, and featured news and press releases. It<br />

also reviews key players involved in the therapeutic development for <strong>Blepharitis</strong> and special<br />

features on late-stage and discontinued projects.<br />

www.aarkstore.com


Scope<br />

- The report provides a snapshot of the global therapeutic landscape of <strong>Blepharitis</strong><br />

- The report reviews key pipeline products under drug profile section which includes, product<br />

description, MoA and R&D brief, licensing and collaboration details & other developmental<br />

activities<br />

- The report reviews key players involved in the therapeutics development for <strong>Blepharitis</strong> and<br />

enlists all their major and minor projects<br />

- The report summarizes all the dormant and discontinued pipeline projects<br />

- A review of the <strong>Blepharitis</strong> products under development by companies and universities/research<br />

institutes based on information derived from company and industry-specific sources<br />

- <strong>Pipeline</strong> products coverage based on various stages of development ranging from pre-registration<br />

till discovery and undisclosed stages<br />

- A detailed assessment of monotherapy and combination therapy pipeline projects<br />

- Coverage of the <strong>Blepharitis</strong> pipeline on the basis of target, MoA, route of administration and<br />

molecule type<br />

www.aarkstore.com


Reasons to buy<br />

- Provides strategically significant competitor information, analysis, and insights to formulate<br />

effective R&D development strategies<br />

- Identify emerging players with potentially strong product portfolio and create effective counterstrategies<br />

to gain competitive advantage<br />

- Develop strategic initiatives by understanding the focus areas of leading companies<br />

- Identify and understand important and diverse types of therapeutics under development for<br />

<strong>Blepharitis</strong><br />

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline<br />

- Devise corrective measures for pipeline projects by understanding <strong>Blepharitis</strong> pipeline depth and<br />

focus of Indication therapeutics<br />

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners<br />

with the most attractive projects to enhance and expand business potential and Scope<br />

www.aarkstore.com


Table of Contents<br />

Introduction 5<br />

Global Markets Direct Report Coverage 5<br />

<strong>Blepharitis</strong> Overview 6<br />

Therapeutics Development 7<br />

<strong>Pipeline</strong> Products for <strong>Blepharitis</strong> - Overview 7<br />

<strong>Pipeline</strong> Products for <strong>Blepharitis</strong> - Comparative Analysis 8<br />

<strong>Blepharitis</strong> - Therapeutics under Development by Companies 9<br />

<strong>Blepharitis</strong> - <strong>Pipeline</strong> Products Glance 10<br />

www.aarkstore.com


List Of Tables<br />

Number of Products under Development for <strong>Blepharitis</strong>, <strong>H1</strong> <strong>2015</strong> 7<br />

Number of Products under Development for <strong>Blepharitis</strong> - Comparative Analysis, <strong>H1</strong> <strong>2015</strong> 8<br />

Number of Products under Development by Companies, <strong>H1</strong> <strong>2015</strong> 9<br />

Comparative Analysis by Late Stage Development, <strong>H1</strong> <strong>2015</strong> 10<br />

Comparative Analysis by Clinical Stage Development, <strong>H1</strong> <strong>2015</strong> 11<br />

Comparative Analysis by Early Stage Development, <strong>H1</strong> <strong>2015</strong> 12<br />

Comparative Analysis by Unknown Stage Development, <strong>H1</strong> <strong>2015</strong> 13<br />

Products under Development by Companies, <strong>H1</strong> <strong>2015</strong> 14<br />

www.aarkstore.com


List Of Figures<br />

Number of Products under Development for <strong>Blepharitis</strong>, <strong>H1</strong> <strong>2015</strong> 7<br />

Number of Products under Development for <strong>Blepharitis</strong> - Comparative Analysis, <strong>H1</strong> <strong>2015</strong> 8<br />

Number of Products under Development by Companies, <strong>H1</strong> <strong>2015</strong> 9<br />

Assessment by Monotherapy Products, <strong>H1</strong> <strong>2015</strong> 19<br />

Number of Products by Top 10 Targets, <strong>H1</strong> <strong>2015</strong> 21<br />

Number of Products by Stage and Top 10 Targets, <strong>H1</strong> <strong>2015</strong> 22<br />

Number of Products by Top 10 Mechanism of Actions, <strong>H1</strong> <strong>2015</strong> 23<br />

Number of Products by Stage and Top 10 Mechanism of Actions, <strong>H1</strong> <strong>2015</strong> 24<br />

Number of Products by Top 10 Routes of Administration, <strong>H1</strong> <strong>2015</strong> 25<br />

www.aarkstore.com


Related Market Research reports:<br />

• Ocular Hypertension - <strong>Pipeline</strong> <strong>Review</strong>, <strong>H1</strong> <strong>2015</strong><br />

• Transitional Cell Cancer (Urothelial Cell Cancer) - <strong>Pipeline</strong> <strong>Review</strong>, <strong>H1</strong> <strong>2015</strong><br />

• Actinic (Solar) Keratosis - <strong>Pipeline</strong> <strong>Review</strong>, <strong>H1</strong> <strong>2015</strong><br />

• Allergic Rhino-Conjunctivitis - <strong>Pipeline</strong> <strong>Review</strong>, <strong>H1</strong> <strong>2015</strong><br />

• Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - <strong>Pipeline</strong> <strong>Review</strong>,<br />

<strong>H1</strong> <strong>2015</strong><br />

www.aarkstore.com


Related Market Research reports:<br />

• Myocardial Ischemia - <strong>Pipeline</strong> <strong>Review</strong>, <strong>H1</strong> <strong>2015</strong><br />

• Thalassemia - <strong>Pipeline</strong> <strong>Review</strong>, <strong>H1</strong> <strong>2015</strong><br />

• Encephalomyelitis - <strong>Pipeline</strong> <strong>Review</strong>, <strong>H1</strong> <strong>2015</strong><br />

• T-Cell Leukemia - <strong>Pipeline</strong> <strong>Review</strong>, <strong>H1</strong> <strong>2015</strong><br />

• Peripheral T-Cell Lymphomas (PTCL) - <strong>Pipeline</strong> <strong>Review</strong>, <strong>H1</strong> <strong>2015</strong><br />

www.aarkstore.com


<strong>Aarkstore</strong> - <strong>Blepharitis</strong> - <strong>Pipeline</strong><br />

<strong>Review</strong>, <strong>H1</strong> <strong>2015</strong><br />

Format<br />

Price<br />

PDF $ 2000<br />

Site Licence $ 4000<br />

Enterprise Wide Licence $ 6000<br />

www.aarkstore.com


Contact Us<br />

Office<br />

Office No. - 809, 8th Floor,<br />

B-Wing, Mahaavir Icon,<br />

Plot No.- 89 & 90, Sector-15,<br />

CBD-Belapur, Navi Mumbai – 400614,<br />

Maharashtra, India.<br />

24/7 Online Support: +91 9987295242<br />

General Inquiries : +91 - 22 2756 4953<br />

You Can Visit : http://www.aarkstore.com<br />

OR Mail us at : contact@aarkstore.com<br />

Blog : http://www.aarkstore.com/blog/<br />

Conference : http://conference.aarkstore.com/<br />

News : http://www.aarkstore.com/news<br />

www.aarkstore.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!